Indications
Therapeutic Asset Ratings
6,299 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
bnt327
Lung Cancer
BioNTech SE
P1/2
CC
(45)
Bpi-1178
Hormone Receptor-Positive Breast Cancer
Beta Pharma (Suzhou) Co., Ltd.
P1/2
CC
(45)
br790
Cancer
Shanghai Gopherwood Biotech Co., Ltd.
P1/2
CC
(45)
Briquilimab
Beta Thalassemia
National Heart, Lung, and Blood Institute (NHLBI)
P1/2
CC
(45)
Briquilimab
Sickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI)
P1/2
CC
(45)
Brl-101
Beta Thalassemia
Bioray Laboratories
P1/2
CC
(45)
Bsb-1001
Myelodysplastic Syndrome
BlueSphere Bio, Inc
P1/2
CC
(45)
bt02
Plasma Cell Myeloma
Biotroy Therapeutics
P1/2
CC
(45)
Bumetanide
Hepatocellular Carcinoma
Memorial Sloan Kettering Cancer Center
P1/2
CC
(45)
Bxq-350
Colorectal Carcinoma
Bexion Pharmaceuticals, Inc.
P1/2
CC
(45)
Camonsertib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
University of Utah
P1/2
CC
(45)
Camonsertib
Metastatic Malignant Neoplasm
Memorial Sloan Kettering Cancer Center
P1/2
CC
(45)
Car.70/Il15-Transduced Cb-Nk Cells
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P1/2
CC
(45)
Car.70/Il15-Transduced Cb-Nk Cells
Myelodysplastic Syndrome
M.D. Anderson Cancer Center
P1/2
CC
(45)
Carbidopa
Multiple System Atrophy, Parkinsonian Type
Julien Bally
P1/2
CC
(45)
Carbon Nanoparticle-Loaded Iron
Thyroid Cancer
Sichuan Enray Pharmaceutical Sciences Company
P1/2
CC
(45)
Carbon Nanoparticle-Loaded Iron
Neoplasm
Sichuan Enray Pharmaceutical Sciences Company
P1/2
CC
(45)
cd19/cd20 dual-car-t cells
B-Cell Non-Hodgkin Lymphoma
Beijing Tsinghua Chang Gung Hospital
P1/2
CC
(45)
CD318-CAR-T cells
Pancreatic Neoplasm
University Hospital Tuebingen
P1/2
CC
(45)
CD47/SIRPA-BLOCKING AGENT ALX148
Aggressive B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(45)
CD47/SIRPA-BLOCKING AGENT ALX148
Indolent B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(45)
CD56 CAR-NK cells
Small Cell Lung Carcinoma
Beijing Biotech
P1/2
CC
(45)
cd5-targeted car-t cells
Precursor T-Cell Acute Lymphoblastic Leukemia
Peking University People's Hospital
P1/2
CC
(45)
ce120
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(45)
Cetuximab
Metastatic Malignant Neoplasm In The Brain
Institut de Recherches Internationales Servier
P1/2
CC
(45)
Showing 3451 to 3475 of 6,299 assets
Previous
Page 139 of 252
Next